Galderma, Novartis layoffs

Share this article:

Galderma is laying off employees. The Dallas/Fort Worth Healthcare Daily reported the layoffs Dec. 9, quoting a company statement that the layoffs are part of a reorganization that will have an impact on the Fort Worth headquarters and other US locations.

The change follows president Francois Fournier's October departure, but the Star-Telegram's Tarrant Business blog reports that the drug company says the layoffs and the president's resignation are not connected.

Novartis is also cutting staff. The Globe and Mail reports that the company will shutter its Mississauga, Ontario, plant next year and will scuttle 300 manufacturing jobs along with the closure.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.